August 6, 2007 AnaptysBio, Inc.: Naturalizing antibodies Urooj Mujtaba BioCentury, The Bernstein Report on BioBusiness Using existing methods to isolate therapeutic antibodies with the desired biological activity can be lengthy, complicated and expensive. By harnessing natural biological mechanisms for creating antibody diversity, Anapyts Biosciences Inc. believes its Omnitope-SHM platform offers speed, cost effectiveness and technical advantages for both the discovery and optimization of therapeutic antibodies in a one-step process. View Original Article/Read More News Main Menu